Načítá se...
Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today the best option beyond heart failure therapy. Prerequisites for this are noninvasive and invasive biomarkers including endomyocardial biopsy and polymerase chain reaction on cardiotropic agents. Imaging by Do...
Uloženo v:
| Vydáno v: | Herz |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Medizin
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096625/ https://ncbi.nlm.nih.gov/pubmed/29947834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00059-018-4719-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|